» Articles » PMID: 39666000

Development and Optimisation of the Biosensor for Aspartate Aminotransferase Blood Level Determination

Overview
Specialty Chemistry
Date 2024 Dec 12
PMID 39666000
Authors
Affiliations
Soon will be listed here.
Abstract

This work presents the development and optimisation of an amperometric biosensor for determining aspartate aminotransferase (AST) activity in blood serum, using glutamate oxidase and platinum disc electrodes. AST is a key biomarker for diagnosing cardiovascular and liver diseases. The biosensor's bioselective membrane composition and formation protocol and the working solution (aspartate 8 mM, α-ketoglutarate 2 mM, pyridoxal-5-phosphate 100 µM) were optimised. The sensor demonstrated high selectivity, stability (70% retention over 2 months at - 18 °C), and sensitivity (2.37 nA min⁻ per 10 U L⁻), with a dynamic range of 0-500 U L⁻ and a limit of detection of 1 U L⁻. Comparative analysis showed the calibration curve method outperforms the standard addition method for AST measurement in serum samples. Additionally, a reference spectrophotometric technique was adapted for AST level determination, showing a strong correlation (r = 0.989) with the biosensor results. This research offers a fast, affordable, and accurate tool for early check-ups of liver and heart conditions. The biosensor's flexibility and ease of use make it suitable for further development into point-of-care testing and personalised healthcare techniques.

References
1.
Thupakula S, Nimmala S, Ravula H, Chekuri S, Padiya R . Emerging biomarkers for the detection of cardiovascular diseases. Egypt Heart J. 2022; 74(1):77. PMC: 9584006. DOI: 10.1186/s43044-022-00317-2. View

2.
Mera J, Dickson B, Feldman M . Influence of gender on the ratio of serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) in patients with and without hyperbilirubinemia. Dig Dis Sci. 2007; 53(3):799-802. DOI: 10.1007/s10620-007-9924-z. View

3.
Liu X, Liu P . Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: a secondary analysis based on a retrospective cohort study. Sci Rep. 2022; 12(1):9231. PMC: 9163143. DOI: 10.1038/s41598-022-13355-2. View

4.
Xuan G, Oh S, Choi E . Development of an electrochemical immunosensor for alanine aminotransferase. Biosens Bioelectron. 2003; 19(4):365-71. DOI: 10.1016/s0956-5663(03)00194-5. View

5.
Sha H, Yan B . Dye-functionalized metal-organic frameworks with the uniform dispersion of MnO nanosheets for visualized fluorescence detection of alanine aminotransferase. Nanoscale. 2021; 13(47):20205-20212. DOI: 10.1039/d1nr05376k. View